196170.KQ
ALTEOGEN Inc.
KOE · Healthcare · Biotechnology · KR
KRW 283,000.00
−5.19%Year over year
Reported trailing growth
- Revenue
- +60.7%
- EBITDA
- +51.1%
- EBIT
- +58.7%
- EPS
- +95.2%
- Free cash flow
- -8.4%
- Operating cash flow
- +12.9%
Forward estimates
Based on analyst estimates
- Revenue
- +130.8%
- EBITDA
- +91.8%
- EPS
- -13.0%
Three-year CAGR
- Revenue
- +95.7%
- EBITDA
- +1918.0%
- EBIT
- +320.8%
- Net income
- +127.6%
- EPS
- +126.4%
- Free cash flow
- +253.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026